
Injective (INJ) gains momentum with a 15% price surge, driven by its EVM testnet launch, soaring on-chain activity, and strategic partnerships with Google Cloud and Deutsche Telekom. (Read More)

Injective (INJ) gains momentum with a 15% price surge, driven by its EVM testnet launch, soaring on-chain activity, and strategic partnerships with Google Cloud and Deutsche Telekom. (Read More)